S100B and autoimmune disease: In addition, substantial evidence has showedthat S100B is associated with pathological injury or clinical severity in a varietyof autoimmune disease (Wang, etal., 2013; Gomez-Tourino,et al., 2015; Lapa,et al., 2017).